FNCRX
Price
$41.69
Change
+$0.29 (+0.70%)
Updated
Jul 13 closing price
Net Assets
487.82M
FRNRX
Price
$42.82
Change
+$0.30 (+0.71%)
Updated
Jul 13 closing price
Net Assets
487.82M
Interact to see
Advertisement

FNCRX vs FRNRX

FNCRX vs FRNRX Comparison Chart in %
View a ticker or compare two or three
VS
FNCRX vs. FRNRX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNCRX is a Buy and FRNRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FNCRX (488M) and FRNRX (488M) have equal amount of cash in the bank . FRNRX pays higher dividends than FNCRX: FRNRX (1.47) vs FNCRX (0.92). FNCRX was incepted earlier than FRNRX: FNCRX (21 years) vs FRNRX (31 years). FNCRX (1.76) is less costly to investors than FRNRX (1.01). FNCRX (19.72) and FRNRX (19.72) have comparable annual turnover. FNCRX (1000) and FRNRX (1000) have matching initial minimum investment requirements. FRNRX (36.70) and FNCRX (35.68) have marching annual gain over last year. FRNRX return over 5 years is better than : 121.43 vs. FNCRX (114.06).
FNCRXFRNRXFNCRX / FRNRX
Total Expense Ratio1.751.00175%
Annual Report Gross Expense Ratio1.761.01174%
Fund Existence21 years31 years-
Gain YTD15.96616.39797%
Front LoadN/A6%-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets488M488M100%
Annual Yield % from dividends0.921.4762%
Returns for 1 year35.6836.7097%
Returns for 3 years53.3156.9094%
Returns for 5 years114.06121.4394%
Returns for 10 years76.0482.9792%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPHA1.79N/A
+0.28%
Innate Pharma SA
PJT157.130.21
+0.13%
PJT Partners
INMD15.15-0.13
-0.85%
InMode Ltd
MLM569.35-8.37
-1.45%
Martin Marietta Materials
PBM2.85-0.12
-4.04%
Psyence Biomedical Ltd.